These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 25742774)

  • 1. The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU).
    Sun D; Liang D; Kaplan HJ; Shao H
    Cytokine; 2015 Jul; 74(1):76-80. PubMed ID: 25742774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells.
    Wang RX; Yu CR; Mahdi RM; Egwuagu CE
    J Biol Chem; 2012 Oct; 287(43):36012-21. PubMed ID: 22936807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
    Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis.
    Ke Y; Sun D; Jiang G; Kaplan HJ; Shao H
    J Immunol; 2011 Sep; 187(5):2130-9. PubMed ID: 21795593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
    Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
    J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBI3 is pivotal for the initiation of experimental autoimmune uveitis.
    Takeda A; Hasegawa E; Fukuhara T; Hirakawa S; Yamada H; Yang Y; Yoshimura T; Hisatomi T; Oshima Y; Yoshida H; Sonoda KH; Ishibashi T
    Exp Eye Res; 2014 Aug; 125():107-13. PubMed ID: 24929202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of antigen specific Th17 cells differentiation in experimental autoimmune uveitis].
    Chen HT; Wang H; Zhao M; Hou B
    Zhonghua Yan Ke Za Zhi; 2012 Mar; 48(3):234-40. PubMed ID: 22800421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of interleukin-17 in uveitis.
    Guedes MC; Borrego LM; Proença RD
    Indian J Ophthalmol; 2016 Sep; 64(9):628-634. PubMed ID: 27853008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.
    Bing SJ; Shemesh I; Chong WP; Horai R; Jittayasothorn Y; Silver PB; Sredni B; Caspi RR
    J Autoimmun; 2019 Jun; 100():52-61. PubMed ID: 30853312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connection between γδ T-cell- and Adenosine- Mediated Immune Regulation in the Pathogenesis of Experimental Autoimmune Uveitis.
    Liang D; Shao H; Born WK; O'Brien RL; Kaplan HJ; Sun D
    Crit Rev Immunol; 2018; 38(3):233-243. PubMed ID: 30004859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
    Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
    Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An A2B Adenosine Receptor Agonist Promotes Th17 Autoimmune Responses in Experimental Autoimmune Uveitis (EAU) via Dendritic Cell Activation.
    Chen M; Liang D; Zuo A; Shao H; Kaplan HJ; Sun D
    PLoS One; 2015; 10(7):e0132348. PubMed ID: 26147733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid inhibits CD25+ dendritic cell expansion and γδ T-cell activation in experimental autoimmune uveitis.
    Liang D; Zuo A; Shao H; Born WK; O'Brien RL; Kaplan HJ; Sun D
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3493-503. PubMed ID: 23611991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine receptor activation in the Th17 autoimmune responses of experimental autoimmune uveitis.
    Li X; Liang D; Shao H; Born WK; Kaplan HJ; Sun D
    Cell Immunol; 2019 May; 339():24-28. PubMed ID: 30249343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines in uveitis.
    Weinstein JE; Pepple KL
    Curr Opin Ophthalmol; 2018 May; 29(3):267-274. PubMed ID: 29521875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis.
    Guo K; Zhang X
    J Immunol Res; 2021; 2021():6693542. PubMed ID: 33816637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines in autoimmune uveitis.
    Horai R; Caspi RR
    J Interferon Cytokine Res; 2011 Oct; 31(10):733-44. PubMed ID: 21787221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.